Wegovy 2,4 mg

Carrello

Casa
Checkout
Negozio
0Lista dei desideri
  1. Casa
  2. La perdita di peso
Prev
Dexanfetamina Tentin 5 mg
Dexanfetamina Tentin 5 mgPrezzo corrente: €80. Prezzo originale era: €90.
Accanto
Ozempic 2mg€170
Ozempic 2mg
Wegovy 2,4 mg

Wegovy 2,4 mg

Sold: 0

€180

Wegovy 2,4 mg rappresenta un potente strumento nella lotta contro l'obesitàsostenuta dalla scienza e mondo reale successo. Se siete pronti a prendere il controllo del vostro peso, parlare con un professionista sanitario, oggi per esplorare se questo farmaco è giusto per te. Ricordate, il cambiamento sostenibile deriva da scelte consapevoli e supporto continuo.

Wegovy 2,4 mg

€180

Aggiungi al carrello
Acquista Ora
Categoria: Tag:

Descrizione Del Prodotto

Wegovy 2,4 mg

Wegovy 2.4 mg (semaglutide) is an FDA-approved prescription injectable medication designed for chronic weight management in adults with obesity or overweight conditions accompanied by weight-related medical issues. Representing the maximum therapeutic maintenance dose, Wegovy 2.4 mg is administered once weekly alongside a reduced-calorie meal plan and increased physical activity to support long-term weight loss.

How Wegovy 2.4 mg Works

Wegovy belongs to a class of medications called glucagon-like peptide-1 (GLP-1) receptor agonists. Semaglutide mimics the naturally occurring GLP-1 hormone produced in the intestines, directly targeting areas of the brain that regulate appetite and food intake.

  • Satiety Enhancement: Promotes a feeling of fullness after meals, reducing overall caloric intake and cravings.

  • Delayed Gastric Emptying: Slows the rate at which food leaves the stomach, helping maintain fullness longer.

  • Cardiovascular Benefits: Reduces the risk of major adverse cardiovascular events in adults with established cardiovascular disease and obesity.

Dosing and Administration Guidelines

Wegovy 2.4 mg is the final maintenance dose reached after a gradual dose-escalation schedule designed to minimize gastrointestinal side effects.

Key Parameter Clinical Recommendation
Amministrazione Subcutaneous injection into the abdomen, thigh, or upper arm once weekly.
Pianificazione Administer on the same day each week, at any time of day, with or without food.
Dose Progression Reached after completing 16 weeks of step-up dosing (0.25 mg to 1.7 mg).

Note: Never increase your dosage or alter your administration schedule without explicit medical supervision from your healthcare provider.

Potential Side Effects and Safety Warnings

While Wegovy 2.4 mg demonstrates strong clinical efficacy for weight loss, awareness of potential side effects and health precautions is essential.

Effetti Collaterali Comuni

  • Nausea, vomiting, and diarrhea

  • Constipation, stomach pain, and heartburn

  • Fatigue, headache, and dizziness

  • Mild injection site reactions

Serious Warnings and Precautions

  • Thyroid Tumor Risk: Contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

  • Acute Pancreatitis: Monitor for persistent, severe abdominal pain that radiates to the back.

  • Hypoglycemia Risk: Increased risk of low blood sugar when used in combination with insulin secretagogues or insulin.

Top
Top